Morphologic and clinical effect of pyrimethamine-sulfonamide combinations (sulformethoxine-pyrimethamine or sulfamonomethoxine-pyrimethamine) on P. vivax and its infection.
D000293:Adolescent; D000328:Adult; D002648:Child; D004338:Drug Combinations; D005260:Female; D005334:Fever; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D010063:Ovum; D010966:Plasmodium vivax / Q000166:cytology* / Q000187:drug effects / Q000302:isolation & purification; D011739:Pyrimethamine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology; D013424:Sulfanilamides / Q000008:administration & dosage / Q000494:pharmacology; D013449:Sulfonamides / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors
D004338:Drug Combinations; D011743:Pyrimidines; D013424:Sulfanilamides; D013449:Sulfonamides; D011739:Pyrimethamine